Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-21-008867
Filing Date
2021-09-20
Accepted
2021-09-20 20:13:06
Documents
1
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A - edgar.html 4/A  
1 FORM 4/A - edgar.xml 4/A 4242
  Complete submission text file 0001179110-21-008867.txt   5840
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address
Woiwode Thomas (Reporting) CIK: 0001619294 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35890 | Film No.: 211264490